Page last updated: 2024-08-17

thymidine and bi 2536

thymidine has been researched along with bi 2536 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cerny-Reiterer, S; Ferenc, V; Gleixner, KV; Hadzijusufovic, E; Herrmann, H; Horny, HP; Mirkina, I; Müllauer, L; Peter, B; Pickl, WF; Schuch, K; Valent, P; Willmann, M; Winter, V1

Other Studies

1 other study(ies) available for thymidine and bi 2536

ArticleYear
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536.
    Haematologica, 2011, Volume: 96, Issue:5

    Topics: Animals; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flow Cytometry; HL-60 Cells; Humans; Immunohistochemistry; K562 Cells; Mast Cells; Mastocytosis, Systemic; Phosphorylation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Thymidine; Tumor Cells, Cultured; U937 Cells

2011